WallStreetZenWallStreetZen

NASDAQ: OPTN
Optinose Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Optinose revenue was $75.67M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $20.4M, down 0.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, OPTN annual revenue was $71.0M, with -6.9% growth year-over-year.

OPTN past revenue growth

How has OPTN's revenue growth performed historically?

Company
5.13%
Industry
14.04%
Market
20.33%
OPTN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OPTN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OPTN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OPTN revenue history

Current Revenue
$75.7M
Current Earnings
-$31.1M
Current Profit Margin
-41.2%

Be the first to know when OPTN announces revenue.

OPTN Revenue History By Year

OPTN Yearly RevenueOPTN RevenueOPTN ChangeOPTN Revenue Growth
2023-12-31$70.99M-$5.29M-6.93%
2022-12-31$76.28M$1.62M+2.18%
2021-12-31$74.65M$25.54M+51.99%
2020-12-31$49.12M$14.49M+41.83%
2019-12-31$34.63M$27.57M+390.18%
2018-12-31$7.07MN/AN/A
2017-12-31$0.00-$47.50M-100.00%
2016-12-31$47.50M$47.42M+55,782.35%
2015-12-31$85.00kN/AN/A

1 of 1

Optinose Revenue FAQ

What was OPTN's revenue last quarter?

On Invalid Date, Optinose (NASDAQ: OPTN) reported Q3 2024 revenue of $20.44 million up 3.1% year over year. In the same quarter last year, Optinose's revenue was $19.82 million.

What was Optinose's revenue in 2023?

Optinose's annual revenue for the twelve months ending Dec 31, 2023 was $70.99 million, a 6.93% decrease year over year.

How much does Optinose make in a day?

Based on Optinose annual revenue for the past five years, OPTN makes an average of $167,486.58 per day.

What was Optinose's annual revenue growth in the past year?

As of Q1 2025, Optinose's revenue has grown 5.13% year over year. This is 8.91 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 14.04%. Optinose's revenue in the past year totaled $75.67 million.

How much does Optinose make in a year?

Optinose's revenue by year for the past five years is:
  • Optinose's revenue for the twelve months ending Dec 31, 2023 was $70.99 million, a 6.93% decrease year over year.
  • Optinose's annual revenue for Dec 31, 2022 was $76.28 million, a 2.18% increase from 2021.
  • Optinose's annual revenue for 2021 was $74.65 million, a 51.99% increase from 2020.
  • Optinose's annual revenue for 2020 was $49.12 million, a 41.83% increase from 2019.
  • Optinose's annual revenue for 2019 was $34.63 million, a 390.18% increase from 2018.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.